Navigation Links
Lilly Reports First-Quarter 2013 Results
Date:4/24/2013

INDIANAPOLIS, April 24, 2013 /PRNewswire/ --

  • Worldwide revenue was flat as growth in key products offset lower Zyprexa revenue following patent expirations.
  • Cymbalta revenue increased 19 percent while Cialis increased 11 percent.
  • Expense controls resulted in lower SG&A, offsetting growth in R&D expense.
  • First quarter 2013 results include income of $495 million related to the transfer to Amylin of exenatide commercial rights outside of the U.S.
  • Tax rate comparisons benefited from the reinstatement of the U.S. R&D tax credit.
  • First quarter earnings per share grew to $1.42 (reported), or $1.14 (non-GAAP).
  • 2013 earnings per share reconfirmed to be in the range of $4.10 to $4.25 (reported), or $3.82 to $3.97 (non-GAAP).
  • Eli Lilly and Company (NYSE: LLY) today announced financial results for the first quarter of 2013.$ in millions, except per share data

    First Quarter

    %20132012

    GrowthTotal Revenue – Reported

    $5,602.0$5,602.0

    0%Net Income – Reported

    1,548.01,011.1

    53%EPS – Reported

     

    1.420.91

    56%Net Income – non-GAAP

    1,247.71,026.9

    22%EPS – non-GAAP

    1.140.92

    24% 

    Financial results for 2013 and 2012 are presented on both a reported and a non-GAAP basis. Some numbers in this press release may not add due to rounding. Reported results were prepared in accordance with generally accepted accounting principles (GAAP) and include all revenue and expenses recognized during the period. Non-GAAP results exclude the items described in the reconciliation tables later in the release. The non-GAAP results are presented in order to provide additional insights into the underlying trends in th
    '/>"/>

    SOURCE Eli Lilly and Company
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. DiversityInc Names Lilly a Top Company for Diversity
    2. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
    3. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
    4. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
    5. Lilly Oncology To Disclose New Pipeline Data At ASCO 2012
    6. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
    7. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
    8. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
    9. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
    10. Lilly Diabetes Launches 8th Annual Diabetes Summer Camp Tour With Olympian Kris Freeman
    11. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... PuraMed BioScience®, Inc., (OTC Pink: PMBS), a ... healthcare products, announced it received the initial funding to ... headache relief product, for planned distribution to 1,000 medical ... , Washington State , and ... H Advanced headache relief gel formulation completed, PuraMed BioScience ...
    (Date:12/24/2014)... 2014 ResMed (NYSE: RMD ) today ... Chinese medical device manufacturer BMC Medical Co., Ltd. ... masks listed below infringe ResMed,s patents, and entered an order ... the United States : , ... , Willow nasal pillows mask , iVolve full face ...
    (Date:12/24/2014)... MASON, Ohio , Dec. 23, 2014 /PRNewswire/ ... industry-leading treatment decision support to healthcare providers for ... that it has secured $30 million in equity ... Virginia C. Drosos , President and Chief ... increased clinical adoption and development of Assurex Health,s ...
    Breaking Medicine Technology:PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4
    ... 2 July, 2007 -- Ablynx today announced ... study of its lead,development programme, ALX-0081, an ... targeting von Willebrand Factor (vWF), which can,reduce ... acute coronary,syndrome. , The Phase I study ...
    ... own blood can,potentially improve the quality of ... by peripheral vascular disease, according,to a study ... /PRNewswire/ -- Beike,Biotechnology Co., Ltd. (<a target="_blank" ... by Dr. Yang Xiaofeng at its,collaborating hospital ...
    Cached Medicine Technology:Ablynx Announces Interim Results of First Nanobody Phase I Study of,ALX-0081 (ANTI-VWF) 2Beike Biotechnology Study Suggests Adult Stem Cells Show Promise,for Peripheral Vascular Disease 2Beike Biotechnology Study Suggests Adult Stem Cells Show Promise,for Peripheral Vascular Disease 3
    (Date:12/25/2014)... 26, 2014 This is a professional ... global Sterilizers industry with a focus on the Chinese ... status of the Sterilizers manufacturers and is a valuable ... interested in the industry. This report provides a basic ... manufacturing technology. In this part, the report presents the ...
    (Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – ... current treatment landscape, unmet needs, current pipeline and commercial ... anti-cancer drug which is typically used for treating colorectal ... for treating gastric cancer and pancreatic cancer. TS-1 is ... was first approved in 1999 in Japan for the ...
    (Date:12/25/2014)... 2014 Recently, iFitDress.com, the popular online supplier ... announced its new selection of black one-shoulder cocktail dresses ... now; they are available at discounted prices, up to 70% ... will last for three weeks only. You know, we have ... are interested in our new items can visit our website ...
    (Date:12/25/2014)... BellasDress has launched its Christmas Sale, offering ... chosen their best-selling lace wedding dresses, vintage bridesmaid dresses ... , Now, BellasDress.com features popular women’s dresses, and ... prices. The business hopes everyone can have a memorable ... “All our elegant products are made with exquisite materials; ...
    (Date:12/25/2014)... Miami, FL (PRWEB) December 25, 2014 When ... often find themselves in a frenzy to get rid of ... classroom. But families in Coral Gables now have the solution ... its second salon clinic location, Lice Troopers provides full spectrum ... in the Coral Gable area, including Sunset, Key Biscayne, Brickell, ...
    Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2
    ... , , WASHINGTON, Sept. 9 ... health care plan, American Life League challenged the nation,s Catholic bishops ... it clear that they prefer this action to compromising with the ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081105/DC44231LOGO ) ...
    ... ... Education Program are Experts in Child Safety , ... Vancouver, BC (PRWEB) September 9, 2009 -- September sees more than 500,000 ... or after school. So how do parents keep their kids safe when they are in ...
    ... Workforce Prescriptions ("WRX") announced on Tuesday the launch of the Paradigm ... by a private endowment, developed to honor hospitals that have gone ... without resorting to workforce reductions or dramatic top-down mandates. , ... the paradigm shift in understanding required to see that the number ...
    ... HILL, N.C., Sept. 9 TSI Healthcare, a national leader in ... recognized in Inc. Magazine,s "Annual Report of the 500|5000 ... successful and innovative businesses in America have been recognized on this ... , , Inc. began publishing this ...
    ... , , DALLAS, Sept. ... new t-shirt design supporting breast cancer research, ... tee will benefit the Dallas County Affiliate of Susan G. Komen ... black and white - features distinctive Katydid Collection designs, pairing bold ...
    ... , , LEHI, ... change and full of demands, pressure and stress. This perfect storm ... depressed population - fueling an $80 billion industry of sleep aids, ... XanGo , LLC unveils eleviv(TM), a revolutionary new ...
    Cached Medicine News:Health News:A.L.L.: Bishops Must Choose Between Christ-Centered Care and Obamacare 2Health News:Keeping Kids Safe Through Education 2Health News:WRX Launches National Labor Efficiency Quality Award 2Health News:WRX Launches National Labor Efficiency Quality Award 3Health News:TSI Healthcare Recognized by Inc. Magazine 2Health News:Katydid Collection Creates Tattoo Inspired Komen Shirts to Support Breast Cancer Awareness 2Health News:Katydid Collection Creates Tattoo Inspired Komen Shirts to Support Breast Cancer Awareness 3Health News:Katydid Collection Creates Tattoo Inspired Komen Shirts to Support Breast Cancer Awareness 4Health News:XanGo Introduces a New Dietary Supplement That Restores Youthful Vigor - Naturally 2Health News:XanGo Introduces a New Dietary Supplement That Restores Youthful Vigor - Naturally 3
    Curved tying forceps made of titanium has curved shafts with 6 mm V-grove tying platforms, width of shafts 0,5 mm, TCI platforms, flat handle, width 10 mm, overall length 103 mm....
    McPherson angled tying forceps made of titanium tying forceps, angled 45 shafts with 6 mm tying platforms, width of shafts 0,25 mm, TCI platforms, flat handle, width 6 mm, overall length 84 mm....
    McPherson straight tying forceps made of titanium, straight shafts with 4 mm tying platforms, width of shafts 0,25 mm, TCI platforms, flat handle, width 6 mm, overall length 87 mm....
    Titanium hoskin suture tying forceps, 4.75"....
    Medicine Products: